Originally published by our sister publication, Pharmacy Practice News
By Gina Shaw
Despite a recent critical blood shortage and an overall decline in plasma donations since the beginning of the COVID-19 pandemic, U.S. supplies of immune globulin (IG) products derived from plasma remain stable, according to market experts.